Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)

Admelog (AD-mah-log) will compete with Humalog as a new BRAND of insulin lispro.

This is similar to the situation with Basaglar and Lantus.

Admelog is not a generic...and isn't technically a biosimilar in the U.S. Instead, FDA calls Admelog and Basaglar "follow-on" brands...they use safety and efficacy data from the original brands for faster approval.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote